Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SARS-COV2 Pandemic Serosurvey and Blood Sampling

NCT04334954 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT04334954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04334954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SARS-COV2 Pandemic Serosurvey and Blood Sampling
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Observational
Overall status
Completed
Start date
August 26, 2020
Completion date
January 21, 2022
Enrollment
11,363 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov2 virus